Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7047
Source ID: NCT01771445
Associated Drug: Il-1ra
Title: Role of Interleukin-1 in the Regulation of Muscle Derived Interleukin-6 During Exercise
Acronym: MUSIL
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: IL-1Ra|DRUG: Placebo
Outcome Measures: Primary: IL6, Change of IL6 during exercise stimulation at baseline compared to change of IL6 during exercise stimulation at day 7 | Secondary: change of inflammatory markers (CRP, Tumor Necrosis Factor alpha, IL-1Ra), Change of inflammatory markers during exercise stimulation at baseline compared to change of inflammatory markers during exercise stimulation at day 7|Muscle soreness, Change in muscle soreness before and after exercise stimulation at baseline compared to change in muscle soreness before and after exercise stimulation at day 7|Activity induced Fatigue (ACTIF) Scale, Change in ACTIF before and after exercise stimulation at baseline compared to change in ACTIF before and after exercise stimulation at day 7|Depression, Change in depression during exercise stimulation at baseline compared to change in depression at day 7|Change of vascular function (CAVI, pulse wave velocity, AVR), Change in vascular function during exercise stimulation at baseline compared to change of vascular function at day 7|glucose metabolism, Change glucose metabolism during exercise stimulation at basleine compared to change in glucose metabolism during exercise stimulation at day 7|Cognition, Change in cognition during exercise stimulation at baseline compared to change in cognition at day 7|Motor strength, Change in motor strength during exercise stimulation at baseline compared to change in motor stength at day 7|Insulin, Change in insulin during exercise stimulation at baseline compared to change in insulin at day 7|Glucagon, Change in glucagon during exercise stimulation at baseline compared to change in glucagon at day 7|GLP-1, Change in GLP-1 during exercise stimulation at baseline compared to change in GLP-1 at day 7|Cortisol, Change in cortisol during exercise stimulation at baseline compared to change in cortisol at day 7|Creatinkinase, Change in creatinkinase during exercise stimulation at baseline compared to change in creatinkinase at day 7|Growth hormone, Change of growth hormone during exercise stimulation at baseline compared to change of growth hormone during exercise stimulation at day 7|Copeptin, Change of copeptin during exercise stimulation at baseline compared to change of copeptin during exercise stimulation at day 7
Sponsor/Collaborators: Sponsor: Marc Y.Donath
Gender: MALE
Age: ADULT
Phases:
Enrollment: 18
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Start Date: 2011-12
Completion Date: 2013-10
Results First Posted:
Last Update Posted: 2014-01-08
Locations: University Hospital of Basel, Division of Endocrinology, Basel, Switzerland
URL: https://clinicaltrials.gov/show/NCT01771445